ProQR Therapeutics NV (PRQR)
1.94
-0.02
(-1.02%)
USD |
NASDAQ |
Apr 26, 16:00
1.945
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Cash from Investing (TTM): 4.631M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.631M |
September 30, 2023 | -0.8001M |
June 30, 2023 | -0.652M |
March 31, 2023 | -0.5621M |
December 31, 2022 | -0.7403M |
September 30, 2022 | -0.9238M |
June 30, 2022 | -0.9076M |
March 31, 2022 | -0.7381M |
December 31, 2021 | -0.5029M |
September 30, 2021 | -0.4181M |
June 30, 2021 | -0.5596M |
March 31, 2021 | -0.8753M |
December 31, 2020 | -1.055M |
September 30, 2020 | -1.213M |
June 30, 2020 | -0.8991M |
March 31, 2020 | -0.6145M |
December 31, 2019 | -0.6493M |
September 30, 2019 | -0.4162M |
June 30, 2019 | -0.4935M |
Date | Value |
---|---|
March 31, 2019 | -0.6168M |
December 31, 2018 | -0.3684M |
September 30, 2018 | -0.3379M |
June 30, 2018 | -0.2568M |
March 31, 2018 | -0.094M |
December 31, 2017 | -0.137M |
September 30, 2017 | -0.1558M |
June 30, 2017 | -0.5704M |
March 31, 2017 | -2.304M |
December 31, 2016 | -2.810M |
September 30, 2016 | -3.008M |
June 30, 2016 | -2.634M |
March 31, 2016 | -1.472M |
December 31, 2015 | -1.469M |
September 30, 2015 | -2.098M |
June 30, 2015 | -2.474M |
March 31, 2015 | -1.977M |
December 31, 2014 | -1.640M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.213M
Minimum
Sep 2020
4.631M
Maximum
Dec 2023
-0.4415M
Average
-0.652M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
uniQure NV | -205.69M |
Merus NV | -27.02M |
argenx SE | -- |
Pharming Group | -129.39M |
Pharvaris NV | -0.0974M |